Scholar Rock Holding (SRRK) Liabilities and Shareholders Equity (2017 - 2026)

Scholar Rock Holding (SRRK) recorded quarterly Liabilities and Shareholders Equity of $535.3 million in Q1 2026, up 32.4% quarter-over-quarter from $404.3 million in Q4 2025, and up 31.33% on a YoY basis from $407.6 million in Q1 2025.

Scholar Rock Holding (SRRK) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Liabilities and Shareholders Equity history runs 10 years deep, the most recent figure standing at $535.3 million for Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity rose 31.33% year-over-year to $535.3 million; the TTM figure through Mar 2026 stood at $1.7 billion (up 31.26% YoY), while the FY2025 annual figure was $404.3 million, down 14.88% from the prior year.
  • Liabilities and Shareholders Equity was $535.3 million for Q1 2026 at Scholar Rock Holding, up from $404.3 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $535.3 million in Q1 2026 to a low of $179.1 million in Q3 2024.
  • Historically, Liabilities and Shareholders Equity has averaged $343.9 million across 5 years, with a median of $340.0 million in 2025.
  • The sharpest annual moves came in 2023 and 2025: Liabilities and Shareholders Equity tumbled 35.77% in 2023, then surged 129.84% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $358.2 million in 2022, then slipped by 13.16% to $311.0 million in 2023, then jumped by 52.69% to $474.9 million in 2024, then slipped by 14.88% to $404.3 million in 2025, then surged by 32.4% to $535.3 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $535.3 million (Q1 2026), $404.3 million (Q4 2025), and $411.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 37.37 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 811.27 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 14.93 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.73 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 23.64 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 33.89 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 12.81 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 26.48 Bn
9 Abivax 91.96 Bn 91.96 Bn - 640.56 Mn
10 Scholar Rock Holding 6.03 Bn 5.55 Bn - 535.25 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 535.25 Mn
Dec 31, 2025 404.27 Mn
Sep 30, 2025 411.72 Mn
Jun 30, 2025 340.05 Mn
Mar 31, 2025 407.55 Mn
Dec 31, 2024 474.92 Mn
Sep 30, 2024 179.13 Mn
Jun 30, 2024 226.87 Mn
Mar 31, 2024 267.29 Mn
Dec 31, 2023 311.04 Mn
Sep 30, 2023 250.69 Mn
Jun 30, 2023 284.90 Mn
Mar 31, 2023 314.72 Mn
Dec 31, 2022 358.17 Mn
Sep 30, 2022 390.30 Mn
Jun 30, 2022 424.13 Mn
Mar 31, 2022 265.98 Mn
Dec 31, 2021 304.45 Mn
Sep 30, 2021 298.39 Mn
Jun 30, 2021 332.05 Mn